
Results
2
2 companies
MedinCell
Market Cap: €889.2m
Engages in the research and development of biodegradable polymer-based processes for the controlled and prolonged delivery of active pharmaceutical ingredients into the human body and animals in France.
MEDCL
€24.76
7D
-2.4%
1Y
53.8%
DBV Technologies
Market Cap: €722.0m
A clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France.
DBV
€2.44
7D
0.4%
1Y
44.0%